SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
Rhea-AI Summary
SS Innovations (Nasdaq: SSII) announced a successful long-distance cross-border telesurgery on May 2, 2026, connecting a surgeon in Perth, Australia to a patient in Indore, India, spanning more than 4,500 miles. The procedure used the SSi Mantra surgical robot and the portable SSi MantrAsana tele-surgeon console.
According to the company, the MantrAsana supports ultra-low latency connectivity, high-definition visualization, and precise instrument control; SS Innovations says the SSi Mantra platform has been used in more than 170 telesurgeries to date.
Positive
- Long-distance telesurgery across >4,500 miles demonstrated on May 2, 2026
- Portable SSi MantrAsana console enables remote procedures from confined spaces
- SSi Mantra platform reported in >170 telesurgeries, showing operational track record
Negative
- No financial impact, commercialization timeline or revenue guidance disclosed in the announcement
Key Figures
Market Reality Check
Peers on Argus
SSII gained 4.36% while peers were mixed: IART +5.66%, BBNX +3.6%, NVCR +3.68%, ESTA +15.93%, AHCO -2.48%. Momentum scanners show no coordinated sector move, indicating the reaction appears stock-specific to SSII’s telesurgery news.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 05 | Utilization milestone | Positive | -3.7% | Reported >10,500 cumulative surgeries and >200 installed systems across 11 countries. |
| Apr 23 | Tech unveiling | Positive | -2.8% | Unveiled new robotic concepts and showcased live telesurgeries at SMRSC 2026. |
| Apr 07 | Conference hosting | Positive | -0.6% | Announced hosting of SMRSC 2026 featuring live telesurgeries and demos. |
| Mar 30 | Regulatory approvals | Positive | +0.2% | Received SSi Mantra approvals in Colombia, Oman, Sri Lanka and Kenya. |
| Mar 18 | Telesurgery approvals | Positive | +7.2% | Gained telesurgery approvals in Indonesia and the Philippines and passed 150 telesurgeries. |
Recent positive operational and innovation updates often met with mixed or negative next-day reactions, with only some regulatory/approval milestones seeing aligned gains.
Over the last few months, SS Innovations has emphasized adoption and global expansion of the SSi Mantra platform. Milestones include new country approvals reported on Mar 18, 2026 and Mar 30, 2026, the SMRSC 2026 conference series in April, and surpassing 10,500 cumulative surgeries by Apr 30, 2026. Despite generally positive operational news, stock reactions were mixed, with several innovation and milestone announcements followed by modest declines. Today’s telesurgery demonstration continues the theme of showcasing cross-border, teleoperated capabilities.
Regulatory & Risk Context
An effective S-3 shelf filed on May 1, 2026 registers up to $150,000,000 of securities and 5,016,500 shares for resale, indicating capacity for future capital raises and secondary sales, though the company notes it only receives proceeds upon warrant exercises.
Market Pulse Summary
This announcement underscores SS Innovations’ focus on long-distance, cross-border telesurgery using the SSi Mantra system and MantrAsana console, with more than 170 telesurgeries performed to date. It builds on recent regulatory and utilization milestones detailed in March–May 2026 filings. Investors may monitor adoption trends, incremental regulatory clearances, and any use of the $150,000,000 S-3 shelf as key indicators of how these technological demonstrations translate into commercial growth and capital needs.
Key Terms
telesurgery medical
surgical robotic system technical
tele-surgeon console technical
gastrojejunostomy medical
ultra-low latency technical
AI-generated analysis. Not financial advice.
Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console
FORT LAUDERDALE, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of a long-distance cross-border telesurgery utilizing the SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) and spanning more than 4,500 miles from the surgeon located at the Royal Australian College of Surgeons in Perth, Australia to the patient in Indore, India.
Dr. Bhandari conducting a live long-distance telesurgery at the Royal Australian College of Surgeons Annual Scientific Congress, utilizing the SSi MantrAsana Tele Surgeon Console
On May 2, 2026, Dr. Mohit Bhandari, President of IRCAD India, remotely performed the live telesurgery, a robotic gastrojejunostomy1, during the Royal Australian College of Surgeons Annual Scientific Congress. To conduct the procedure, Dr. Bhandari utilized the SSi MantrAsana tele-surgeon console, a compact self-contained chair-based version of the larger SSi Mantra surgeon command center that enables portability, requires less space, and facilitates the performance of telesurgeries from a wide range of locations, including physician offices.
The SSi MantrAsana has been engineered for real-time remote procedures through ultra-low latency connectivity, high-definition visualization, and precise instrument control.
To date, more than 170 telesurgeries, including intricate cardiac procedures, have been performed with the SSi Mantra surgical robotic system.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We thank the Royal Australian College of Surgeons for this opportunity to demonstrate the advanced telesurgery capabilities of our SSi Mantra surgical robotic system. I’d also like to congratulate Dr. Bhandari and the SS Innovations team for making possible another successful long-distance cross-border telesurgery with the SSi Mantra. We believe that telesurgery has the power to transform traditional healthcare delivery and democratize access to global surgical expertise. We are proud to be pioneering this revolutionary technology.”
1A gastrojejunostomy is a surgical procedure that creates a new connection between the stomach and the middle small intestine (jejunum) to bypass the duodenum.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana Tele Surgeon Console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that provides equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.com
Devin Sullivan, Managing Director
T: (212) 836-9608
dsullivan@theequitygroup.com
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/08414f3b-4742-459c-a905-bda30b4cc456
